caribou biosciences stock forecast

Ad Ensure Your Investments Align with Your Goals. View the latest Caribou Biosciences Inc.

B3v24ibw0kvu6m

Searching for Financial Security.

. Stock Price Forecast The 7 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 2800 with a high estimate of 3900 and a low estimate of 1900. The average rating for CRBU stock is Buy The 12-month stock price forecast is 2754 which is an increase of 24296 from the latest price. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.

Stock price gained 237 on the last trading day Thursday 26th May 2022 rising from 803 to 822. In last trading session Caribou Biosciences Inc. The average twelve-month price prediction for Caribou Biosciences is 2971 with a high price target of 3900 and a low price target of 1900.

CRBU is currently trading in the 20-30 percentile range relative to its historical Stock Score levels. That CARIBOU BIOSCIENCESs share price could reach 3180 by May 13 2023. According to 13 stock analysts the average 12-month stock price forecast for CRBU stock is 2754 which predicts an increase of 27572.

The highest average and lowest price target of all. 2754 24296 upside. Get a real-time Caribou Biosciences Inc.

Their forecasts range from 1900 to 3900. The current Caribou Biosciences CRBU share price is 855. Caribou Biosciences Inc a clinical-stage biopharmaceutical company engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally.

CRBU Stock Analysis Overview. The current Caribou Biosciences share price is 803. About Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage. The average price target represents a 18658 change from the last price of 663. Based on 5 Wall Street analysts offering 12 month price targets for Caribou Biosciences in the last 3 months.

Caribou Biosciences Inc 855 033 401 Watch. CB-010 is the lead product candidate from Caribous allogeneic CAR-T cell therapy platform and is being evaluated in patients. 733-045 -578 At close.

And has now gained 3 days in a rowIt will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Caribous lead candidate is a therapy to fight B-cell non-Hodgkins Lymphoma. Our Financial Advisors Offer a Wealth of Knowledge.

Find the latest Caribou Biosciences Inc. This suggests a possible upside of 2668 from the stocks current price. Skip to main content.

NASDAQCRBU saw 031 million shares changing hands with its beta currently measuring 0. View analysts price targets for Caribou Biosciences or view top-rated stocks among Wall Street analysts. The demand for shares of the company still looks higher than the supply.

According to the issued ratings of 8 analysts in the last year the consensus rating for Caribou Biosciences stock is Buy based on the current 8 buy ratings for CRBU. The company is making clinical progress. IPO intraday trading strategy idea The share price is rising and gonna continue this trend today.

So I opened a long position from 1813. CRBU is currently trading in the 40-50 percentile range relative to its historical Stock Score levels. Find a Dedicated Financial Advisor Now.

Caribou plans to issue a data press release at 900 am CEST 300 am ET on Friday June 10 2022. What are analysts forecasts for Caribou Biosciences stock. Is Caribou Biosciences Stock Undervalued.

Companys recent per share price level of 1707 trading at -094 or -522 at ring of the bell on the day assigns it a market valuation of 99757M. The Caribou Biosciences Inc. The 9 analysts offering price forecasts for Caribou Biosciences have a median target of.

CRBU stock quote history news and other vital information to help you with your stock trading and investing. The average price target is 1900 with a high forecast of 1900 and a low forecast of 1900. It edits a type.

CRBU IEX Real-Time Price USD. View the latest Caribou Biosciences Inc. Co-founder of Caribou Co-recipient of the 2020 Nobel Prize in Chemistry.

Take-profit 2422MOC price. Market cap market capitalization is the total market value of a publicly traded companys outstanding shares. This suggests a possible upside of 2714 from the stocks current price.

The poster will be available on the Presentations page of the Investors section of Caribous website. During the day the stock fluctuated 545 from a day low at 789 to a day high of 832. The Score for CRBU is 30 which is 40 below its historic median score of 50 and infers higher risk than normal.

Caribou is a leader in the CRISPR field successfully leveraging its proprietary genome-editing technology to develop allogeneic cell therapies that are potentially transformative for patients Jennifer Doudna PhD. On average Wall Street analysts predict. These and other conditions can cause a rise in the share price today.

The average CARIBOU BIOSCIENCES stock price prediction forecasts a potential upside of 28686 from the current CRBU share price of 822. CARIBOU BIOSCIENCES s market cap is calculated by multiplying CRBU s current stock price of 794 by CRBU s total outstanding shares of 60663581. CRBU stock price news historical charts analyst ratings and financial information from WSJ.

Caribou Biosciences Inc. CRBU stock price quote with breaking news financials statistics charts and more. The Score for CRBU is 41 which is 18 below its historic median score of 50 and infers higher risk than normal.

Caribou Biosciences Inc CRBU gets an Overall Rank of 56 which is an above average rank under InvestorsObservers stock ranking system. Get Caribou Biosciences Inc CRBUNASDAQ real-time stock quotes news price and financial information from CNBC. That closing price of CRBUs stock is Caribou Biosciences.

The lowest target is 1919 and the highest is 378. On average they anticipate Caribou Biosciences share price to reach 2971 in the next year. Stock Price Forecast The 7 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 2800 with a high estimate of 3900 and a low estimate of 1900.

Rooms Shows Rankings Earnings Newsletters Shop. Real-time trade and investing ideas on Caribou Biosciences Inc CRBU from the largest community of traders and investors.

Genome Editing Market Share Growth Forecast To 2029 Straitsresearch